Mark Keim
Mr. Keim will continue as the Company’s chief financial officer with expanded operational and growth-related responsibilities
Highest-materiality recent filing
Molina Q3 2026 GAAP EPS $0.73 vs $1.51; revenue $11.08B down 3%; FY guidance reaffirmed
Q3 GAAP diluted EPS $0.73 vs $1.51 a year ago; adjusted EPS $0.89 vs $1.84.
Molina Q2 GAAP EPS $1.19, down 75% YoY; raises full-year guidance
Q2 2026 GAAP EPS $1.19 vs $4.75 YoY; adjusted EPS $1.51 vs $5.48 YoY.
Molina wins Illinois Medicaid contract; go-live Jan 2027, 4.5-year term
Illinois HFS intends to award HealthChoice Illinois Medicaid contract to Molina's Illinois subsidiary.
Molina Q1 GAAP EPS $0.27 vs $5.45 YoY; revenue $10.8B down 3.1%
Adjusted EPS of $2.35 vs $6.08 in prior-year quarter; net income $14M vs $298M.
Molina Healthcare records $93M impairment, eases credit covenant through amendment
Pre-tax non-cash impairment charge of ~$93M in Q1 2026 from exiting Medicare Advantage Prescription Drug product for 2027.
Molina Healthcare reports Q4 GAAP loss of $3.15 per share; full-year 2025 EPS down 56%
Q4 2025 GAAP net loss of $160M vs. net income of $251M in Q4 2024; adjusted loss per share $2.75.
Intends to privately offer $750M senior notes due 2031 to repay existing delayed draw term loans and replace credit facility.
Molina awarded sole Florida Medicaid contract; $5B in annual premiums expected
Florida AHCA selected Molina as sole plan for SMMC and CHIP services for ~120,000 enrollees.
Molina Healthcare Q3 GAAP EPS $1.51 vs $5.65 YoY; full-year guidance revised
Q3 2025 GAAP net income $79M ($1.51 diluted EPS) vs $326M ($5.65) a year ago; adjusted EPS $1.84 vs $6.01.
Molina Q2 GAAP EPS $4.75, down 8% YoY; net income falls to $255M
GAAP net income $255M ($4.75 diluted) vs $301M ($5.17) in Q2 2024; adjusted net income $294M ($5.48) vs $341M ($5.86).
Molina Healthcare cuts FY25 adjusted EPS guidance to $21.50-$22.50; Q2 preliminary $5.50
Q2 2025 preliminary adjusted EPS ~$5.50, modestly below prior expectations due to medical cost pressures across all lines of business.
Molina shareholders reject say-on-pay, approve 2025 equity plan and special meeting proposal
Say-on-pay failed: 26,653,672 votes against vs 18,249,700 for, with 1,848,771 broker non-votes.
Molina Healthcare Q1 GAAP EPS $5.45, Adjusted $6.08; Reaffirms FY2025 Guidance
Total revenue $11.147B, up 12% YoY from $9.931B; premium revenue $10.628B.
Molina wins Illinois D-SNP contract; serves ~73k beneficiaries starting Jan 2026
Molina subsidiary one of four MCOs awarded Illinois D-SNP contract by Dept. of Healthcare & Family Services.
Molina Q4 GAAP EPS $4.44, adjusted $5.05; full-year adjusted EPS $22.65; introduces 2025 guidance
Q4 premium revenue $9,983M (+19% YoY); total revenue $10,499M.
Molina Healthcare closes acquisition of ConnectiCare, adding ~140,000 members
Acquisition of ConnectiCare Holding Company closed effective Feb 1, 2025.
Molina awarded HIDE SNP contract in Michigan; Idaho intends to award MMCP/IMPlus contracts
Michigan MDHHS awarded Molina Healthcare of Michigan a HIDE SNP contract for 11 regions in lower peninsula; go-live Jan 1, 2026.
Michigan cancels Molina's notice of intent to award Medicare dual-eligible contract; re-issues RFP
Michigan procurement office cancelled the notice of intent to award Molina contracts for the Highly Integrated Dual Eligible Special Needs Medicare population.
Molina Q3 GAAP EPS $5.65, adjusted $6.01; reaffirms FY guidance
Q3 premium revenue $9.694B, up 17.6% YoY from $8.24B.
Molina awarded Michigan contract for dual-eligible plan MI Coordinated Health; go-live Jan 2026
Michigan DHHS awarded Molina Healthcare of Michigan a HIDE SNP contract for six service regions.
Molina Healthcare increases revolver to $1.25B, extends maturity to 2029
Revolving credit facility increased from $1.0B to $1.25B.
Molina Healthcare Q2 2024 adj EPS $5.86 beats prior year $5.65; reaffirms FY guide
GAAP EPS $5.17 (vs $5.35 YoY); adjusted EPS $5.86 (vs $5.65 YoY).
Molina Q1 GAAP EPS $5.17, adjusted $5.73; revenue rises to $9.93B; reaffirms FY2024 guidance
Q1 GAAP EPS $5.17 vs $5.52 YoY; adjusted EPS $5.73 vs $5.81.
Molina Healthcare wins Michigan Medicaid contract in six service regions; go-live Oct 1, 2024
Michigan DHHS intends to award a Comprehensive Health Care Program contract to Molina Healthcare of Michigan.
Molina not selected for Virginia's Cardinal Care contract; current deal continues into summer 2024
Molina Healthcare of Virginia was not chosen as an awardee in the Commonwealth's Cardinal Care Managed Care program.
Molina Healthcare Q4 GAAP EPS $3.70, adjusted $4.38; FY2023 GAAP EPS $18.77
Q4 premium revenue $8.36B (+5.6% YoY), total revenue $9.05B; MCR 89.1%, G&A 7.1%.
Molina Healthcare closes Bright Healthcare California Medicare buy; adds 109K members
Acquisition of Bright Healthcare's California Medicare business closed effective January 1, 2024.
Molina Healthcare amends Bright HealthCare deal; purchase price cut to ~$425M from $510M
Purchase price reduced to ~$425M (net of tax benefits) from previously announced $510M.
Molina Healthcare Q3 GAAP EPS $4.21, adjusted $5.05; revenue up 7.8% YoY
GAAP EPS $4.21 (Q3 2022: $3.95); adjusted EPS $5.05 (Q3 2022: $4.36).
Molina Healthcare of New Mexico awarded Medicaid contract; go-live July 2024
New Mexico HSD intends to award Molina a Medicaid managed care contract under the Turquoise Care program.
Molina Healthcare Q2 GAAP EPS $5.35, adj. $5.65; raises full-year guidance
GAAP EPS $5.35, adjusted EPS $5.65; net income $309M, up 24.6% YoY ($248M).
Molina Healthcare to acquire Bright HealthCare's California Medicare business for $510M
Purchase price ~$510M, net of tax benefits; represents 28% of expected 2023 premium revenue of $1.8B.
Mr. Keim will continue as the Company’s chief financial officer with expanded operational and growth-related responsibilities
Mr. Woys assumed the role of the Company’s chief operating officer
Max materiality 0.85 · Median 0.65 · Most common event earnings